Related by context. All words. (Click for frequent words.) 71 azficel T 67 Ophena TM 66 HuMax EGFr 64 MAGE A3 ASCI 64 pain palliation 64 Artelon ® 64 noninfectious uveitis 64 Dr. Kauvar 64 NP2 Enkephalin 63 TG# [003] 63 cobiprostone 63 analgesic efficacy 63 Golimumab 62 Vascugel ® 62 Capesaris 62 ALA PDT 62 ToGA 62 topical diclofenac 62 CIMZIA ™ 62 Extina 62 Juvederm Ultra 62 afamelanotide 62 treat facial wrinkles 62 bardoxolone methyl 62 pharmacokinetic PK study 62 facial contouring 62 wilate ® 61 CINQUIL 61 INC# 61 Levulan PDT 61 RSD# oral 61 riociguat 61 EVOLENCE R 61 pharmacodynamics PD 61 Panzem R NCD 61 OncoVEX GM CSF 61 preclinically 61 Afatinib 61 LibiGel ® 61 ZYBRESTAT fosbretabulin 61 Restylane Perlane 61 elure 61 vidofludimus 61 fosbretabulin 61 topical formulation 61 Ophena 60 glabellar lines 60 liposomal amphotericin B 60 pharmacokinetic equivalence 60 MACUGEN 60 ecabet sodium 60 anti angiogenic therapy 60 Pemetrexed 60 Solesta 60 ZACTIMA 60 VA# [002] 60 LATISSE ™ 60 vascular disrupting agents 60 lasofoxifene 60 ESBA# 60 Asclera 60 Tarceva TM 60 Phase IIB 60 Ketotransdel 60 Isolagen Therapy TM 60 PREOS 60 Elagolix 60 dextofisopam 60 budesonide foam 60 DAVANAT 60 Prevelle Silk 60 phase IIa clinical 60 Azedra 60 seborrheic dermatitis 60 efficacy tolerability 60 miconazole Lauriad R 60 depsipeptide 60 LEUKINE 60 LUVENIQ 60 Plenaxis TM 60 GOUT 60 Aflibercept 60 cutaneous lupus 60 QLT# 60 Pivotal Phase III 60 collagen crosslinking 60 romidepsin 60 Zoraxel 60 UPLYSO 60 pharmacodynamic properties 59 PRECISE 59 Alequel ™ 59 oral prodrug 59 Anturol 59 INFUSE ® 59 prucalopride 59 Gabapentin GR 59 imiquimod 59 phase IIIb 59 EVOLENCE ® 59 ACZ# 59 alicaforsen enema 59 tanespimycin 59 cartilage regeneration 59 hypertrophic scars 59 apremilast 59 diabetic macular edema DME 59 Aggrastat ® tirofiban hydrochloride 59 teriflunomide 59 CYT# potent vascular disrupting 59 JAK inhibitors 59 Pharmacokinetic studies 59 Excellagen 59 prospective randomized controlled 59 ZOLINZA 59 biologic DMARD 59 cilengitide 59 Xanafide 59 CBLC# 59 ZYBRESTAT 59 TACI Ig 59 EcoNail 59 teriparatide 59 Cimzia TM 59 EKC Cide 59 brivaracetam 59 Archexin 59 Topical Suspension 59 Oral NKTR 59 Epiduo 59 BAL# [002] 59 DDP# 59 Degarelix 59 nab paclitaxel 59 XP #L 59 imiquimod cream 59 Traficet EN 59 sorafenib Nexavar 59 Aquamid 59 bazedoxifene conjugated estrogens 59 trabedersen 59 PRADAXA 59 actinic keratosis 59 preclinical efficacy 59 incyclinide 59 BEMA TM Fentanyl 59 Zemplar Capsules 59 pharmacokinetic PK profile 59 Anturol TM 58 Aplidin 58 oral Xeloda 58 PERLANE 58 systemic immunosuppressive drugs 58 briakinumab 58 PXD# 58 diarrhea predominant irritable 58 ganetespib 58 Hypoactive Sexual Desire Disorder 58 IRX 2 58 Oracea TM 58 tigecycline 58 Sudhir Agrawal D.Phil 58 Sublative Rejuvenation 58 HDL Selective Delipidation 58 alemtuzumab MS 58 LB# [003] 58 urethral bulking agent 58 Hyphanox 58 Myocet 58 oral ridaforolimus 58 EVIZON 58 Spiegelmer ® 58 pan HDAC inhibitor 58 plasma kallikrein inhibitor 58 thymalfasin 58 STRIDE PD 58 Amplimexon 58 ADAGIO study 58 velafermin 58 Zybrestat 58 painful diabetic neuropathy 58 Alequel 58 placebo controlled clinical 58 arzoxifene 58 ACAPODENE 58 Cardio Vascu Grow 58 TPI ASM8 58 Benign Prostatic Hyperplasia BPH 58 Peyronie Disease 58 diabetic neuropathic pain 58 Onychomycosis 58 pharmacodynamic parameters 58 XmAb# 58 actinic keratoses 58 efalizumab 58 Vandetanib 58 tazarotene 58 Genzyme Synvisc 58 microplasmin 58 pharmacodynamic PD 58 metastatic neuroendocrine tumors 58 biologic therapy 58 Ozurdex 58 dermatological diseases 58 Catena ® 58 Dalbavancin 58 eltrombopag 58 Perceiva 58 MGd 58 indibulin 58 favorable pharmacokinetic profile 58 masitinib 58 Safinamide 58 Prospective Randomized 58 calcium hydroxylapatite 58 plasma kallikrein 58 galiximab 58 olopatadine 58 topically applied 58 PsA 58 CR# vcMMAE 58 pomalidomide 58 PEG SN# 58 Fibrin Pad 58 investigational monoclonal antibody 58 acne rosacea 58 Qutenza TM 58 Trofex 58 ACTEMRA TM 58 OZURDEX 58 percutaneous vertebroplasty 58 luliconazole 58 phototoxicity 58 dysmenorrhea 58 Cannabinor 58 INCB# [003] 58 adecatumumab 58 clevidipine 58 pharmacodynamic profile 58 Silodosin 58 Phase IIIb clinical 58 CCX# 58 sorafenib tablets 58 Zenvia Phase III 57 AZILECT ® 57 pharmacokinetics PK 57 antitumor effect 57 MoxDuo 57 enzastaurin 57 acetonide FA 57 Darusentan 57 severe gastroparesis 57 zotarolimus 57 LUMINATE 57 edifoligide E2F Decoy 57 teduglutide 57 Chrysalin 57 O PPDS 57 nasolabial fold wrinkles 57 calcineurin inhibitors 57 Vascugel 57 SmartLipo Triplex 57 relapsed MM 57 Entereg R 57 randomized multicenter trial 57 PROCHYMAL 57 Dacogen injection 57 pimecrolimus 57 Dupuytren Disease 57 obatoclax 57 rFIXFc 57 safety tolerability pharmacokinetic 57 GORE VIABAHN Endoprosthesis 57 CA4P 57 CRLX# 57 cortical stimulation 57 Pivotal Trial 57 OvaRex R 57 Ketotransdel TM 57 multitargeted 57 AzaSite Plus 57 treat benign prostatic 57 Levulan ® PDT 57 Onconase 57 fibrotic disease 57 Tß4 57 CRVO 57 tocilizumab 57 NEVO TM 57 Adhesion Barrier 57 phase IIb clinical 57 diabetic macular edema 57 Phase 2a trial 57 topical NSAID 57 dose proportionality 57 pharmacokinetic characteristics 57 pharmacodynamic effects 57 delivers fluocinolone acetonide FA 57 CAPHOSOL 57 anti angiogenic drugs 57 Zyclara 57 reslizumab 57 cannabinor 57 toenail onychomycosis 57 Nebido 57 rifalazil 57 menadione 57 HuLuc# 57 topical antifungal 57 recurrent glioma 57 RADIESSE 57 OHR/AVR# 57 GLYX 57 BioVant 57 Diamondback #deg 57 Androxal TM 57 huC# DM4 57 topical retinoid 57 OMS# 57 randomized Phase IIb 57 CLENZIderm 57 orBec 57 Orthokine 57 varespladib 57 hylan GF 57 NATRECOR ® 57 prospective multicentre 57 aflibercept VEGF Trap 57 MYCAMINE 57 thalidomide Thalomid 57 EchoCRT 57 Emollient Foam 57 Ostabolin C 57 Phase #/#a 57 OMNARIS HFA 57 Virulizin ® 57 ziconotide 57 Pyratine 6 57 endoluminal 57 oral rivaroxaban 57 convenient dosing regimens 57 A3 adenosine receptor 57 florbetaben 57 Phase IIb clinical trials 57 trodusquemine 57 Acanya Gel 57 Teriflunomide 57 acne vulgaris 57 IMA# 57 INSPIRE Trial Phase III 57 ILLUMINATE 57 #F FDG PET 57 Polyphenon ® E 57 PRTX 57 Glypromate 57 adalimumab 57 PyratineXR 57 erythema redness 57 sodium benzoate prescription 57 Vfend 57 DU #b 57 investigational therapies 57 NOXAFIL 57 YONDELIS 57 AGHD 57 esophageal candidiasis 57 BrachySil 57 TissuGlu 57 ruboxistaurin 57 INT# [002] 57 kidney urologic 57 Onrigin 57 Augment Injectable 57 Clolar ® 57 Raptiva ® 57 Photodynamic Therapy PDT 57 Soriatane 57 Zorbtive TM 57 invasive candidiasis 57 Apoptone 57 CIPN 57 SUTENT ® 57 photodamaged skin 57 azelaic acid 57 Aclidinium 57 Phenoptin 57 acitretin 56 pharmacodynamic profiles 56 Noxafil 56 visilizumab 56 TRANSFORMS 56 dermaPACE ™ 56 MetroGel 56 EpiCeram 56 psoriatic 56 selective A2A adenosine receptor 56 photocoagulation 56 Bendavia 56 CANCIDAS 56 CIMZIA TM certolizumab pegol 56 subcutaneously administered 56 PROMACTA 56 caspofungin 56 MGuard ™ 56 Octreolin 56 histone deacetylase inhibitor 56 Pimavanserin 56 Retisert TM 56 acyclovir Lauriad R 56 optimal dosing regimens 56 BRIM2 56 topical formulations 56 pharmacokinetics pharmacodynamics 56 Fludara ® 56 elagolix 56 Abbott HUMIRA 56 S/GSK# 56 crizotinib PF # 56 DermaVir Patch 56 posaconazole 56 TLK# 56 phase IIb study 56 efaproxiral 56 Phase 1b trial 56 Excellarate 56 Sculptra ® 56 octreotide implant 56 AMEVIVE 56 pediatric Crohn disease 56 multicenter Phase II 56 PrevOnco ™ 56 injectable implant 56 DUROS 56 Interferon alpha 56 KRN# 56 formerly LymphoStat B 56 deferiprone 56 CoFactor 56 scalp psoriasis 56 choroidal neovascularization 56 radezolid 56 Eculizumab 56 fallopian tube cancers 56 metastatic RCC 56 pertuzumab 56 mertansine 56 Hylaform 56 superficial basal cell carcinoma 56 Aldara Cream 56 fibromyalgia syndrome 56 icatibant 56 antiangiogenic therapy 56 Acute Ischemic Stroke 56 Cellegesic 56 Teriparatide 56 Tyrima 56 HQK 56 ocular allergies 56 Taclonex R 56 alvespimycin 56 esophagogastric 56 R Saizen R 56 NUVIGIL 56 DACH platinum 56 Carvedilol 56 immunomodulatory properties 56 transurethral 56 Squalamine 56 desvenlafaxine 56 Inhalation Solution 56 myelofibrosis polycythemia vera 56 hyaluronic acid dermal fillers 56 RADIESSE dermal filler 56 EOquin TM 56 SinuNase TM 56 Retisert 56 SinuNase 56 sipuleucel T 56 Phase IIIb study 56 anti arrhythmic 56 RESTYLANE 56 Cerashield 56 angiotensin analog 56 VICTOR E3 56 serotonin norepinephrine reuptake inhibitor 56 Revimmune 56 topical retinoids 56 SNT MC# 56 NEVO ™ 56 STARFlex R 56 EmbraceAC 56 TH# [003] 56 ConclusionThis 56 thromboembolic disease 56 Torisel 56 polidocanol 56 ACUROX ® 56 ALGRX 56 HCV protease inhibitors 56 miconazole Lauriad ® 56 ANAVEX #-# [001] 56 atacicept 56 topical acne 56 Vernakalant 56 photoprotection 56 radiographic outcomes 56 metaglidasen 56 Relieva 56 Factor VIIa 56 NasalFent 56 Tolvaptan 56 MP4OX 56 vaginal candidiasis 56 CG# [003] 56 diclofenac sodium 56 REMINYL ® 56 Fibrin Patch 56 Bronchial Thermoplasty 56 clinical pharmacology studies 56 injectable dermal filler 56 PresbyLens ® 56 constipation OIC 56 pegaptanib 56 docetaxel Taxotere ® 56 Evoltra ® 56 delafloxacin 56 RoACTEMRA 56 TASKi3 56 elotuzumab 56 catheter occlusion 56 JAK inhibitor 56 Phase #b/#a 56 alvimopan 56 tezampanel 56 GAMMAGARD 56 neovascular 56 Cimzia ® certolizumab pegol 56 injectable filler 56 bowel syndrome Non 56 EUFLEXXA TM 56 PLX cells 56 NGX# 56 OMS#HP 56 benign prostatic hypertrophy BPH 56 Phase Ib study 56 isavuconazole 56 GEM OS1 56 topical NSAIDs 56 Proxinium TM 56 tasocitinib 56 Urea Cycle Disorder 56 Factor Xa inhibitor 56 morphometric vertebral fractures 56 rALLy 56 TOLAMBA 56 GFT# 56 TELINTRA 56 tacrolimus ointment 56 forodesine 56 Zevalin consolidation 56 Diabetic Neuropathy 56 L PPDS 56 Effexor venlafaxine 56 neovascular diseases 56 Protelos 56 INFUSE Bone Graft 56 INCB# [001] 56 Cardium Therapeutics TM 56 ALVESCO HFA 56 mg kg BID 56 BrachySil TM 56 Anti VEGF 56 CellerateRx 55 Sym# 55 Carfilzomib 55 photoprotective drug 55 preclinical pharmacokinetic 55 Zenvia ™ 55 SPRYCEL ® 55 AzaSite Xtra 55 induced macular edema 55 ELACYT 55 hypertrophic scarring 55 PRT# 55 VivaGel ® 55 immunomodulatory agents 55 Metvix 55 nonrandomized 55 BCG refractory carcinoma 55 MicroPulse 55 tolerability pharmacokinetics 55 Medidur 55 Stelara 55 etanercept Enbrel 55 EXPAREL ™ 55 pimecrolimus cream 55 herpetic keratitis 55 Microplasmin 55 FOLPI 55 mycophenolate mofetil 55 Kepivance 55 Dual Opioid 55 multicenter trials 55 pharmacokinetic pharmacodynamic 55 HuMax CD# 55 vismodegib 55 opioid induced bowel dysfunction 55 phakic 55 erythema edema 55 phase IIb III 55 oncological outcomes 55 alefacept 55 bimatoprost 55 RezularTM 55 nosocomial pneumonia 55 antiangiogenic agents 55 Sanctura XR 55 urothelial cancer 55 periorbital 55 colesevelam HCl 55 potency selectivity 55 confirmatory clinical 55 venous stasis ulcers 55 NAVISTAR R 55 symptomatic paroxysmal AF 55 Fluorouracil 55 anti androgens 55 bevacizumab Avastin 55 viral kinetic 55 Ranibizumab 55 photodamage 55 ADVANCE PD 55 brand ciclesonide HFA 55 ATL# [001] 55 Eli Lilly Cymbalta 55 hormone LHRH antagonist 55 MAL PDT 55 SILENOR 55 torezolid phosphate 55 TORISEL 55 elacytarabine 55 dosage regimens 55 EDEMA3 trial 55 HuMax CD4 55 Imiquimod 55 LT NS# 55 Nexrutine 55 KRAS status 55 HairMax 55 AVANDIA 55 GLP toxicology studies 55 TLR agonists 55 Hydrelle 55 ranibizumab Lucentis 55 LHRH antagonists 55 RAPAFLO 55 demonstrated antitumor activity 55 iSONEP 55 tramiprosate 55 glycopyrrolate 55 bevacizumab Avastin ® 55 efficacy endpoint 55 Zyclara Cream 55 1mg 2mg 55 ROTARIX 55 Alocrest 55 antithrombotics 55 novel VDA molecule 55 XGEVA 55 BioSTAR R 55 Dasatinib 55 uricase 55 alpha interferons 55 PARP inhibition 55 zolmitriptan 55 hypoparathyroidism 55 BRAF inhibitor 55 Gelnique 55 Vidofludimus 55 orally inhaled 55 Complicated Skin 55 pharmacokinetic interactions 55 Dabigatran etexilate 55 antitumour activity 55 antitumor effects 55 TNF alpha inhibitor 55 Hedgehog inhibitor 55 pseudobulbar affect PBA 55 urate lowering 55 antiarrhythmic drug 55 IMGN# 55 phase IIb 55 conjunctival hyperemia 55 phase IIa 55 MoxDuo IR 55 RE COVER 55 PEGylated interferon 55 ENMD # 55 tipranavir 55 KRAS mutation 55 dexpramipexole 55 pouchitis 55 InterStim Therapy 55 refractory gout 55 phase Ib 55 ustekinumab 55 constipation predominant irritable bowel 55 vemurafenib 55 Imprime PGG 55 XYZAL R 55 Loceryl ® 55 Phase #b/#a trial 55 Fodosine 55 CaPre TM 55 Rebif ® 55 DexaSite 55 sunitinib malate 55 AZX# 55 cediranib 55 oral deforolimus 55 recurrent herpes labialis 55 RAPAFLO R 55 CIMZIA TM 55 amifostine 55 neratinib 55 Chemophase 55 GnRH agonists 55 CYT# QbG# 55 multicenter Phase III 55 orally dosed 55 inhibitor RG# 55 topically administered 55 MacuSight 55 lip augmentation 55 SomatoKine 55 PSN# [002] 55 presbyopia correcting 55 intranasal delivery 55 pharmacokinetic PK 55 ritonavir boosted 55 balsalazide tablet 55 Lubiprostone 55 antiarrhythmic 55 ixabepilone 55 immune modulating 55 abatacept 55 lucinactant 55 p# inhibitor 55 inflammatory acne vulgaris 55 cystinosis patients 55 LymphoStat B 55 vaginally administered lidocaine 55 orally inhaled migraine 55 Angioedema 55 Doxil ® 55 dermal 55 Elocalcitol 55 Simulect 55 histamine dihydrochloride 55 GORE TAG Device 55 Darinaparsin 55 Anidulafungin 55 vorinostat 55 Aryplase 55 Phase IIa trial 55 ataluren 55 relapsed MCL 55 Cx# [002] 55 pancreatic carcinoma 55 goserelin 55 HGS# 55 QuadraSphere 55 triamcinolone 55 eMatrix 55 viral kinetics 55 Ustekinumab 55 pramlintide metreleptin combination 55 Egrifta 55 Generx 55 ibandronate 55 hyaluronic acid fillers 55 bendamustine 55 somatostatin analogues 55 JUVEDERM TM 55 Sculptra Aesthetic 55 Hycamtin 55 CRMD# 55 Menadione 55 vertebral compression fractures 55 ATIR 55 GEM OS2 55 QTc prolongation 55 Synavive 55 EFAPROXYN 55 CA9 SCAN 55 TBC# 55 Sandostatin LAR 55 non constipation irritable 55 Phase 1a clinical 55 severe hypersensitivity reactions 55 LLLT 55 Dapagliflozin 55 BST CarGel R 55 sulodexide 55 myocardial revascularization 55 Symadex 55 evaluating tivozanib 55 ketoprofen patch 55 IL# PE#QQR 55 infusional 55 Voltaren Gel 55 Menerba 55 interferon beta therapy 55 ruxolitinib 55 dose limiting toxicities 55 tiapamil 55 phase IIb trial 55 rhITF 55 gemifloxacin 54 Firazyr 54 inflammatory lesions 54 juvenile idiopathic arthritis 54 hemostatic efficacy 54 TEMODAL 54 using Innocoll proprietary 54 LY# [003] 54 Seprafilm 54 myeloproliferative diseases 54 NLX P# 54 Pruvel 54 choroidal vasculopathy 54 NeuroStar TMS Therapy 54 PSMA ADC 54 antithrombotic therapy 54 corneal ectasia 54 retinal vein occlusion 54 Bezielle 54 placebo controlled studies 54 XIENCE V stent 54 iniparib 54 Juvederm Restylane 54 statistically significant superiority 54 dabigatran etexilate 54 rhytids 54 PGL# 54 Proquin XR 54 tumor lysis syndrome 54 valdecoxib 54 MultiStat 54 basal bolus regimen 54 dermatologic diseases 54 palifermin 54 Nestorone 54 decitabine 54 Toctino ® alitretinoin 54 antimuscarinic 54 MEK inhibitors 54 Targretin 54 fondaparinux 54 Critical Limb Ischemia CLI 54 immunomodulation 54 Diabetic Macular Edema 54 EVICEL 54 allogeneic HSCT 54 REOLYSIN ® 54 canakinumab 54 aromatase inhibitors AIs 54 mecamylamine 54 dorzolamide 54 FOLOTYN ® 54 Cancidas 54 injectable gel 54 Vectibix monotherapy 54 mTOR inhibition 54 ACTEMRA 54 INCB# [002] 54 limiting toxicity DLT 54 onabotulinumtoxinA 54 urography 54 MGN# 54 trospium 54 atypical Hemolytic Uremic Syndrome 54 Clonicel 54 oral talactoferrin 54 demonstrated clinically meaningful 54 favorable tolerability 54 keloid scars 54 HoLEP 54 Laser Lok 54 REMURA 54 Zarnestra 54 collagen fillers 54 everolimus eluting stents 54 Striking Skin Care 54 counter brand ESOTERICA 54 Vashe Wound Therapy 54 conivaptan 54 intranasal corticosteroid 54 AAG geldanamycin analog 54 maximally tolerated dose 54 Efudex 54 selective modulator 54 Diovan HCT 54 hyperkeratotic 54 overactive bladder syndrome 54 multicentre randomized 54 ciclopirox 54 EGFRIs 54 neovascular form 54 cangrelor 54 Targretin capsules 54 multiple myeloma MM 54 treating acne scars 54 Phase Ib clinical trials 54 aflibercept 54 BENLYSTA ® 54 photoaging 54 Phase 2b study 54 Neulasta ® 54 gefitinib Iressa 54 Fortical R 54 CDK inhibitor 54 inflammatory acne 54 proton pump inhibitor PPI 54 PEG uricase 54 anticancer activity 54 pan histone deacetylase 54 liposomal formulation 54 filler Restylane 54 nasal antihistamine 54 mitomycin C 54 SERMs 54 Tissue Matrix 54 Alvesco R 54 ProSavin 54 Zirgan 54 relapsing multiple sclerosis 54 novel histone deacetylase 54 tumorigenicity 54 androgenetic alopecia 54 lapatinib Tykerb 54 bovine thrombin 54 bioequivalency 54 mechanistic insights 54 vinca alkaloid 54 Serdaxin 54 dermatologic conditions 54 solithromycin 54 Radiesse ® 54 SPRIX ® 54 thetreatment 54 telangiectasia 54 ALCL 54 SEPET TM 54 R roscovitine 54 nociceptive pain 54 strontium ranelate 54 GnRH antagonist 54 osteoarthritic 54 gel formulation 54 Ciclesonide 54 GentleWaves 54 topical gel formulation 54 tecarfarin 54 anti androgen 54 Zingo TM 54 SNT-MC#/idebenone 54 EP #R 54 C1 INH 54 Dermal Fillers 54 RE LY 54 viscosupplementation 54 Campath alemtuzumab 54 arthrography 54 HuMax 54 Cotavance 54 rALLy clinical trial 54 Pharmacokinetic 54 zalutumumab 54 null responder 54 Ereska 54 efficacy 54 anidulafungin 54 cutaneous T cell 54 pharmacokinetic profiles 54 elective PCI 54 Focalin XR 54 osteoconductive 54 Duromist ™ 54 SCH # 54 Fibrostat R 54 baminercept 54 Taclonex Scalp R 54 Combo Stent 54 fidaxomicin 54 vildagliptin 54 functional mitral regurgitation 54 Etanercept 54 randomized blinded